Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer on 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer

被引：1
|
作者：
Mendenhall, N. P. [1 ]
Hoppe, B. S. [1 ]
Morris, C. G. [1 ]
Nichols, R. C. [1 ]
Mendenhall, W. M. [1 ]
Su, Z. [1 ]
Li, Z. [1 ]
Williams, C. R. [2 ]
Costa, J. [2 ]
Henderson, R. H. [1 ]
机构：
[1] Univ Florida, Proton Therapy Inst, Jacksonville, FL USA
[2] Univ Florida, Coll Med, Dept Surg, Div Urol, Jacksonville, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.400
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [41] Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    Freeman, Debra E.
    King, Christopher R.
    RADIATION ONCOLOGY, 2011, 6
  • [42] Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer
    Henderson, Randal H.
    Bryant, Curtis
    Hoppe, Bradford S.
    Nichols, R. Charles
    Mendenhall, William M.
    Flampouri, Stella
    Su, Zhong
    Li, Zuofeng
    Morris, Christopher G.
    Mendenhall, Nancy P.
    ACTA ONCOLOGICA, 2017, 56 (07) : 963 - 970
  • [43] Proton Therapy in the Management of High-Risk Prostate Cancer
    Bryant, C. M.
    Henderson, R. H.
    Hoppe, B. S.
    Mendenhall, W. M.
    Nichols, R.
    Su, Z.
    Li, Z.
    Williams, C. R.
    Morris, C. G.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S420 - S420
  • [44] CONCOMITANT HYPOFRACTIONATED IMRT BOOST FOR LOCALIZED HIGH-RISK PROSTATE CANCER: FIVE YEAR RESULTS OF A PROSPECTIVE TRIAL
    Cheung, Patrick
    Morton, Gerard
    Szumacher, Ewa
    Danjoux, Cyril
    Chung, Hans
    Vesprini, Danny
    Chu, William
    Choo, Richard
    Deabreu, Andrea
    Zhang, Liying
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S38 - S38
  • [45] Clinical outcome of permanent prostate brachytherapy for low-, intermediate-, and high-risk cases.
    Yagi, Yasuto
    Nakamura, Ken
    Ozu, Choichiro
    Nishiyama, Toru
    Toya, Kazuhito
    Yorozu, Atsunori
    Saito, Shiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
    Potosky, AL
    Davis, WW
    Hoffman, RM
    Stanford, JL
    Stephenson, RA
    Penson, DF
    Harlan, LC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (18) : 1358 - 1367
  • [47] Outcomes of High-Dose Rate Brachytherapy for Intermediate- to High-Risk Prostate Cancer at One Institution
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E927 - E927
  • [48] Interstitial low dose rate brachytherapy for prostate cancer - A focus on intermediate- and high-risk disease
    Khaksar, S. J.
    Langley, S. E. M.
    Lovell, D.
    Laing, R. W.
    CLINICAL ONCOLOGY, 2006, 18 (07) : 513 - 518
  • [49] Clinical Outcomes of Very High-risk Prostate Cancer Treated with Proton Therapy
    Sosa, Alan
    Choi, Seungtaek
    Nguyen, Quynh-Nhu
    Kudchadker, Reena
    Sanders, Jeremiah
    Zhu, Ronald
    Shah, Shalin
    Mok, Henry
    Kuban, Deborah
    Mayo, Lauren
    Hoffman, Karen
    Tang, Chad
    McGuire, Sean
    Ausat, Noveen
    Thames, Howard
    Frank, Steven
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S5 - S5
  • [50] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345